November 2017

Welcome to our
new-look newsletter.

Professor James Whisstock
EMBL Australia Scientific Head
The last few weeks have been an exceptionally exciting time for our laboratory network. We hosted our first Scientific Summit, which was a huge amount of fun, and I think that a lot of great new collaborative interactions will grow out of the conversations we had during this meeting. 

The beginning of October also saw the announcement of the Nobel Prize in Chemistry to Jacques Dubochet, Joachim Frank and Richard Henderson. Jacques Dubochet performed his pioneering work on cryo-EM whilst at EMBL, and it is wonderful that his contribution to cryo-EM and structural biology has been recognised in this way.

I’m extremely pleased that over the past 18 months our laboratory network has almost doubled, with new group leaders appointed - or being appointed - at Monash University, the Garvan Institute of Medical Research, the QIMR Berghofer Medical Research Institute and the Australian National University.

We have a large number of events filling the calendar in the final few months of year. We recently held our inaugural Scientific Summit and a Group Leader retreat. Later this month, leaders from across our laboratory network will congregate for our Strategic Summit and the annual EMBL Australia Postgraduate Symposium (EAPS) will be held in Sydney.

Lastly, we look forward to welcoming EMBL Director General Iain Mattaj to Australia in June next year.

Max Cryle wins fellowship to battle antimicrobial resistance

Congratulations to EMBL Australia Group Leader Associate Professor Max Cryle, who has been awarded a Career Development Fellowship from the National Health and Medical Research Council. ​

Read more

Group leaders awarded ARC Discovery Project grants

Associate Professor Edwina McGlinn and Dr Maté Biro have each been awarded grants for their respective projects investigating genome structure and regulation and biological mathematics.

Read more

Dr Harald Janovjak named a ‘Scientist to Watch’

The newest Group Leader to join our Partner Laboratory Network, 
Dr Harald Janovjak, was recently profiled as a ‘Scientist to Watch’ in renowned life sciences magazine,
The Scientist.

Read the full profile

EMBL Australia researcher awarded a Victoria Fellowship

Postdoctoral research fellow Dr Jennifer Payne has been awarded a prestigious Victoria Fellowship to expand her work using cutting-edge techniques to battle the antibiotic-resistant ‘superbug’.

Read more

David Lynn on the importance of incentivising Open Science

Reassessing the metrics that measure scientific impact is one way to incentivise the open sharing of data and research, EMBL Australia Group Leader Associate Professor David Lynn tells EMBL-ABR. 

Read his full interview

Aussie contingent shines at EMBL PhD Symposium

Thirteen promising Australian PhD students had the "invaluable opportunity" to attend the 19th EMBL PhD Symposium in Heidelberg, Germany, thanks to EMBL Australia travel grants.

Upcoming events

EMBL-ABR will hold national training workshops on Genome Annotation using Apollo with Monica Munoz-Torres on 21 November at EMBL-ABR nodes in QLD, NSW, VIC and SA.

EMBL-ABR will host their second All Hands Meeting at the University of New South Wales on Tuesday, 28 November. All with an interest in bioinformatics are welcome to attend.

The 4th EMBL Australia Postgraduate Symposium (EAPS) will be hosted by the Garvan Institute for Medical Research in Sydney on 29 November – 1 December.

AMSI BioInfoSummer 2017 will be hosted by Monash University on 4 – 8 December.

AMSI Summer School 2018 will be hosted by Monash University on 8 January – 2 February, 2018.
See more events

Recent publications

Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell
Apaja PM
Nat Commun. 2017 Aug 30;8(1):398.
Halogenation of glycopeptide antibiotics occurs at the amino acid level during non-ribosomal peptide synthesis
Cryle MJ
Chem Sci. 2017 Sep 1;8(9):5992-6004.
A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome
Apaja PM
Biochim Biophys Acta. 2017 Oct;1864(10):1554-1565. 
Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl- channel function and trafficking
Apaja PM
J Physiol. 2017 Sep 14. 
Multivariable Analysis of Nutritional and Socio-Economic Profiles Shows Differences in Incident Anemia for Northern and Southern Jiangsu in China
Ville-Petteri Mäkinen
Nutrients 2017, 9(10),1153.


Associate Professor Mikaël Martino is an EMBL Australia Group Leader, based at the Australian Regenerative Medicine Institute, Monash University. 


Tell us a little bit about yourself:
I am Swiss and French, but I mostly grew up in the French part of Switzerland where I did my all of my studies. After my PhD and a short postdoc in Switzerland (EPFL), I moved to Japan where I focussed on how the immune system controls tissue healing. I joined EMBL Australia in mid-2016.

What are your scientific interests?
Ultimately, I want to create new therapeutics for regenerative medicine and make regenerative medicine a wide-spread clinical reality.

What has been a highlight of your research career to date?
Discovering that the immune system is indeed a critical actor in the tissue repair and regeneration processes.
Which unresolved question would you most like to answer?
Why can't humans, as mammals, regenerate most of their tissues?
What are the best ways to reprogram our body towards real tissue regeneration, as opposed to scarring and tissue repair?

Name one tool you can’t do without. 
Genetic and injury animal models, in particular, the mouse.

What’s the best advice you’ve ever received?
Focus on what really matters and try to find simple solutions to complicated problems. It is particularly important in the field of regenerative medicine.

Read more about Mikaël's work
Please forward our quarterly newsletter to colleagues who may like to keep up-to-date with EMBL Australia events, news and opportunities throughout the year.
Copyright © 2017 EMBL Australia, All rights reserved. 
Update your preferences or unsubscribe from this list.